Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 4
1989 4
1990 4
1993 1
1994 1
1997 1
1998 3
1999 3
2000 7
2001 14
2002 11
2003 12
2004 14
2005 24
2006 24
2007 19
2008 26
2009 30
2010 16
2011 28
2012 18
2013 18
2014 15
2015 16
2016 7
2017 6
2018 13
2019 13
2020 21
2021 9
2022 12
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

352 results
Results by year
Filters applied: . Clear all
Page 1
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
Powles T, Park SH, Voog E, Caserta C, Valderrama BP, Gurney H, Kalofonos H, Radulović S, Demey W, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N, Kopyltsov E, Sternberg CN, Bellmunt J, Aragon-Ching JB, Petrylak DP, Laliberte R, Wang J, Huang B, Davis C, Fowst C, Costa N, Blake-Haskins JA, di Pietro A, Grivas P. Powles T, et al. Among authors: kalofonos h. N Engl J Med. 2020 Sep 24;383(13):1218-1230. doi: 10.1056/NEJMoa2002788. Epub 2020 Sep 18. N Engl J Med. 2020. PMID: 32945632 Clinical Trial.
In Reply.
Papachristos A, Kemos P, Kalofonos H, Sivolapenko G. Papachristos A, et al. Among authors: kalofonos h. Oncologist. 2020 Dec;25(12):e2023. doi: 10.1002/onco.13565. Epub 2020 Oct 26. Oncologist. 2020. PMID: 33044037 Free PMC article.
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
Powles T, Park SH, Voog E, Caserta C, Valderrama BP, Gurney H, Kalofonos H, Radulovic S, Demey W, Ullén A, Loriot Y, Sridhar SS, Tsuchiya N, Kopyltsov E, Sternberg CN, Bellmunt J, Aragon-Ching JB, Petrylak DP, Laliberte RJ, Huang B, Costa N, Blake-Haskins JA, Grivas P. Powles T, et al. Among authors: kalofonos h. Future Oncol. 2022 Jun;18(19):2361-2371. doi: 10.2217/fon-2021-1631. Epub 2022 Apr 13. Future Oncol. 2022. PMID: 35416053 Free article. Review.
Anti-PD-1 associated retroperitoneal fibrosis.
Daoussis D, Kraniotis P, Kalofonou F, Kalofonos H. Daoussis D, et al. Among authors: kalofonos h. Rheumatology (Oxford). 2021 Sep 1;60(9):e329-e330. doi: 10.1093/rheumatology/keab264. Rheumatology (Oxford). 2021. PMID: 33729466 No abstract available.
Radiotherapy and Renal Cell Carcinoma: A Continuing Saga.
Spyropoulou D, Tsiganos P, Dimitrakopoulos FI, Tolia M, Koutras A, Velissaris D, Lagadinou M, Papathanasiou N, Gkantaifi A, Kalofonos H, Kardamakis D. Spyropoulou D, et al. Among authors: kalofonos h. In Vivo. 2021 May-Jun;35(3):1365-1377. doi: 10.21873/invivo.12389. Epub 2021 Apr 28. In Vivo. 2021. PMID: 33910814 Free PMC article. Review.
Bortezomib-induced peripheral neurotoxicity: an update.
Argyriou AA, Cavaletti G, Bruna J, Kyritsis AP, Kalofonos HP. Argyriou AA, et al. Among authors: kalofonos hp. Arch Toxicol. 2014 Sep;88(9):1669-79. doi: 10.1007/s00204-014-1316-5. Epub 2014 Jul 29. Arch Toxicol. 2014. PMID: 25069804 Review.
Cardiovascular effects of treatment with taxanes.
Peroukides S, Alexopoulos A, Kalofonos H, Papadaki H. Peroukides S, et al. Among authors: kalofonos h. J Cardiovasc Med (Hagerstown). 2012 May;13(5):319-24. doi: 10.2459/JCM.0b013e3283529060. J Cardiovasc Med (Hagerstown). 2012. PMID: 22476001 Review.
The Fire Within: NF-κB Involvement in Non-Small Cell Lung Cancer.
Dimitrakopoulos FD, Kottorou AE, Kalofonou M, Kalofonos HP. Dimitrakopoulos FD, et al. Among authors: kalofonos hp. Cancer Res. 2020 Oct 1;80(19):4025-4036. doi: 10.1158/0008-5472.CAN-19-3578. Epub 2020 Jul 2. Cancer Res. 2020. PMID: 32616502 Review.
Molecularly targeted therapies for malignant gliomas.
Argyriou AA, Kalofonos HP. Argyriou AA, et al. Among authors: kalofonos hp. Mol Med. 2009 Mar-Apr;15(3-4):115-22. doi: 10.2119/molmed.2008.00123. Mol Med. 2009. PMID: 19148300 Free PMC article. Review.
352 results